BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 441.4 Million SEK | 21.43% |
| 2022 | 34.56 Million USD | 10.87% |
| 2021 | 31.17 Million USD | 21.02% |
| 2020 | 25.76 Million USD | 4.01% |
| 2019 | 24.76 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 11.31 Million USD | -19.08% |
| 2024 Q1 | 8.49 Million SEK | -25.54% |
| 2024 Q2 | 152.93 Million SEK | 62.89% |
| 2023 Q1 | 8.92 Million USD | -2.89% |
| 2023 Q4 | 12.05 Million USD | 27.42% |
| 2023 FY | 41.97 Million USD | 21.43% |
| 2023 Q3 | 9.46 Million USD | -3.57% |
| 2023 Q2 | 9.81 Million USD | 10.01% |
| 2022 Q2 | 9.71 Million USD | 0.0% |
| 2022 FY | 34.56 Million USD | 10.87% |
| 2022 Q4 | 9.18 Million USD | 21.25% |
| 2022 Q3 | 7.57 Million USD | -22.01% |
| 2021 FY | 31.17 Million USD | 21.02% |
| 2020 FY | 25.76 Million USD | 4.01% |
| 2019 FY | 24.76 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -408.617% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -8875.413% |
| SQZ Biotechnologies Company | 85.61 Million USD | -415.543% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -1393.598% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -1084.794% |
| Mesoblast Limited | 5.9 Million USD | -7378.872% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -29289.659% |
| Genus plc | 147.7 Million USD | -198.851% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -4927.808% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -32802.586% |
| Marizyme, Inc. | 19.23 Million USD | -2194.214% |
| ContraFect Corporation | 56.88 Million USD | -675.902% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -5193.237% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -9912.153% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -29749.698% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -15036.057% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -15718.872% |
| MultiCell Technologies, Inc. | 567.42 USD | -77791130.482% |
| Accustem Sciences Inc. | 3.74 Million USD | -11681.998% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -413.588% |
| EV Biologics, Inc. | 531.96 Thousand USD | -82876.416% |
| Q BioMed Inc. | 3.43 Million USD | -12744.073% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -1685.972% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -113206.346% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -16699.212% |
| Biomind Labs Inc. | 994.18 Thousand USD | -44298.611% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | -95.752% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -6470.438% |
| Skye Bioscience, Inc. | 13.54 Million USD | -3158.176% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -21445.464% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 1765712.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -8654.446% |
| IMV Inc. | 37.7 Million USD | -1070.544% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -2657.005% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -23953.414% |
| GB Sciences, Inc. | 1.42 Million USD | -30973.58% |
| Alpha Cognition Inc. | 9.7 Million USD | -4447.92% |
| HST Global, Inc. | 140.9 Thousand USD | -313158.39% |
| CSL Limited | 3.44 Billion USD | 87.202% |
| Halberd Corporation | 74.84 Thousand USD | -589679.803% |
| Enzolytics Inc. | 2.17 Million USD | -20152.424% |
| Resverlogix Corp. | 12.71 Million USD | -3372.333% |
| Affymax, Inc. | 39.38 Million USD | -1020.71% |
| SYBLEU INC | 160.87 Thousand USD | -274274.674% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -11990.891% |
| argenx SE | 1.53 Billion USD | 71.217% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -668.459% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -42179.981% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -27848.308% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -12863.457% |
| AVAX Technologies, Inc. | 7.31 Million USD | -5938.127% |
| Zenith Capital Corp. | 8.94 Million USD | -4835.737% |
| Genscript Biotech Corporation | 825.34 Million USD | 46.519% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -2533640.887% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -17877.434% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -257264.337% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -344.38% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -24984.305% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -22283.133% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -23575.719% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -3961.866% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -22878.896% |
| BioStem Technologies, Inc. | 22.97 Million USD | -1821.248% |
| ONE Bio Corp. | 6.44 Million USD | -6749.944% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -243117.346% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -32953.224% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -39138.961% |
| Agentix Corp. | 1.37 Million USD | -32077.953% |
| LadRx Corporation | 3.81 Million USD | -11479.937% |
| Cell Source, Inc. | 4.32 Million USD | -10105.033% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -106139.545% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -47696.234% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -47696.234% |
| NovAccess Global Inc. | 2.46 Million USD | -17794.032% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -18254.059% |
| Itoco Inc. | 919.14 Thousand USD | -47923.322% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -10314.344% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -39346.202% |
| Kadimastem Ltd | 2.41 Million USD | -18214.626% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -168550.803% |
| CytoDyn Inc. | 18.05 Million USD | -2344.363% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -1753656.605% |
| Mobile Lads Corp. | 554.54 Thousand USD | -79497.184% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -200466.617% |
| Qrons Inc. | 643.67 Thousand USD | -68475.233% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -30989.272% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -19694.931% |
| Rebus Holdings, Inc. | 664 Thousand USD | -66376.355% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -24202.05% |
| International Stem Cell Corporation | 5.27 Million USD | -8274.179% |
| Bioxytran, Inc. | 3.82 Million USD | -11454.608% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -838399.677% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -2169702.881% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -1117.126% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -27180.779% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -59886.682% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -14088.46% |
| Neutra Corp. | 243.82 Thousand USD | -180935.678% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -2428.516% |
| PureTech Health plc | 144.59 Million USD | -205.264% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -2054.248% |
| IXICO plc | 4.7 Million USD | -9277.587% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -4917.654% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -274.871% |
| CSL Limited | 3.89 Billion USD | 88.662% |
| Cellectis S.A. | 97.32 Million USD | -353.558% |